Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Med Klin Intensivmed Notfmed ; 107(6): 485-7, 2012 Sep.
Article in German | MEDLINE | ID: mdl-22802213

ABSTRACT

Intra-abdominal and intrathoracic misplacement is a possible complication after insertion of a chest drain but perforation of the left ventricle has very rarely been described. We report on a 57-year-old woman who had to be resuscitated due to circulatory insufficiency subsequent to cardiogenic and hemorrhagic shock after the insertion of a chest drain for the treatment of a postpneumonic pleural effusion. During surgery perforation of the left ventricle with hemopericardium was found. Despite an initially unfavorable situation the patient recovered well.


Subject(s)
Chest Tubes/adverse effects , Foreign Bodies/diagnosis , Foreign Bodies/therapy , Heart Arrest/etiology , Heart Arrest/therapy , Heart Ventricles/injuries , Pleural Effusion/therapy , Activities of Daily Living/classification , Cardiac Tamponade/diagnosis , Cardiac Tamponade/therapy , Cooperative Behavior , Echocardiography , Female , Follow-Up Studies , Humans , Hypoxia-Ischemia, Brain/diagnosis , Hypoxia-Ischemia, Brain/etiology , Hypoxia-Ischemia, Brain/therapy , Interdisciplinary Communication , Middle Aged , Patient Care Team , Physical Therapy Modalities , Rehabilitation, Vocational , Respiratory Distress Syndrome/diagnosis , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/therapy
2.
J AOAC Int ; 88(1): 5-15, 2005.
Article in English | MEDLINE | ID: mdl-15759720

ABSTRACT

In 1996, U.S. Food and Drug Administration regulations mandated the fortification of enriched cereal-grain products with folic acid, thereby emphasizing the need for validated methods for total folates in foods, particularly cereal products. The AOAC Official Methods (944.12, 960.46) currently used for the analysis of folate in foods for compliance purposes are microbiological methods. When the fortification regulations were finalized, no Official AOAC or Approved AACC methods for folate in cereal-grain products were in place. The AOAC Official Method (992.05) for folic acid in infant formula does not incorporate important improvements in the extraction procedure and was not considered suitable for the analysis of folates in foods in general. A microbiological assay protocol using a trienzyme extraction procedure was prepared and submitted for comments to 40 laboratories with recognized experience in folate analysis. On the basis of comments, the method was revised to have the conjugase (gamma-glutamyl-carboxy-peptidase) treatment follow a protease treatment, to include the use of cryoprotected inoculum, and to include the spectroscopic standardization of the standard and optional use of microtiter plates. Thirteen laboratories participated in a collaborative study of 10 required and 10 optional cereal-grain products, including flour, bread, cookies, baking mixes, and ready-to-eat breakfast cereals. The majority of the participating laboratories performed the assay by the standard test tube method; others used the microtiter plate modification for endpoint quantitation with equal success. For the required products, the relative standard deviation between laboratories (RSD(R)) ranged from 7.4 to 21.6% for 8 fortified (or enriched) products compared with expected (Horwitz equation-based) values of 11-20%. RSD(R) values were higher (22.7-52.9%) for 2 unfortified cereal-grain products. For the optional products, the RSD(R) ranged from 1.8 to 11.2% for 8 fortified products. RSD(R) values were higher (27.9-28.7%) for 2 unfortified cereal-grain products. Based on the results of the collaborative study, the microbiological assay with trienzyme extraction is recommended for adoption as Official First Action.


Subject(s)
Chemistry Techniques, Analytical/methods , Edible Grain/metabolism , Food Analysis/methods , Food, Fortified , Lactobacillus/metabolism , Spectrophotometry/methods , Automation , Bread , Folic Acid/analysis , Folic Acid/chemistry , Folic Acid Deficiency/prevention & control , Guidelines as Topic , Humans , Hydrogen-Ion Concentration , Laboratories , Nephelometry and Turbidimetry , Nutrition Policy , Oxygen/metabolism , Quality Control , Reproducibility of Results
3.
Neurosci Lett ; 269(3): 178-82, 1999 Jul 16.
Article in English | MEDLINE | ID: mdl-10454161

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF) is a potent and specific neurotrophic factor for dopaminergic neurons. GDNF has been previously shown to protect dopaminergic neurons from lesion-induced degeneration in vivo. In this study we investigated the effect of GDNF on 6-hydroxydopamine (6-OHDA)-treated dopaminergic neurons in vitro. In dissociated cultures of embryonic rat mesencephalon, 6-OHDA exhibited a dose-dependent cytotoxicity on tyrosine hydroxylase (TH)-immunoreactive neurons. After pre-treatment with GDNF, however, 6-OHDA-induced loss of dopaminergic neurons was effectively reduced. It has been shown recently that GDNF signals through the receptor tyrosine kinase Ret and the GDNF receptor-alpha (GFR-alpha). By RT-PCR, we found both Ret- and GFR-alpha-genes to be expressed in the cultured mesencephalic cells. We propose that the neuroprotective effect of GDNF on 6-OHDA-treated dopaminergic neurons in vitro is most likely mediated by functional Ret receptor signaling pathways.


Subject(s)
Cell Survival/drug effects , Dopamine/physiology , Drosophila Proteins , Mesencephalon/cytology , Nerve Growth Factors , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Oxidopamine/toxicity , Proto-Oncogene Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , Animals , Cells, Cultured , Embryo, Mammalian , Gene Expression Regulation/drug effects , Glial Cell Line-Derived Neurotrophic Factor , Glial Cell Line-Derived Neurotrophic Factor Receptors , Neurons/cytology , Neurons/metabolism , Oxidopamine/antagonists & inhibitors , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-ret , Rats , Receptor Protein-Tyrosine Kinases/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Tyrosine 3-Monooxygenase/metabolism
4.
J Neurochem ; 72(6): 2531-8, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10349864

ABSTRACT

Effects of estrogen hormones on lipid peroxidation (LPO) were examined in rat brain homogenates (RBHs), hippocampal HT 22 cells, rat primary neocortical cultures, and human brain homogenates (HBHs). Dose-response curves indicated half-maximal effective concentrations (EC50) of 5.5 and 5.6 mM for iron-induced LPO in RBHs and HT 22 homogenates. Incubation of living rat primary neocortical cultures with iron resulted in an EC50 of 0.5 mM, whereas culture homogenates showed an EC50 of 1.2 mM. Estrogen hormones reduced LPO in all systems: In RBHs, estrone inhibited iron-induced LPO to 74.1 +/- 5.8% of control levels (17beta-estradiol: 71.3 +/- 0.1%) at a concentration of 10 microM. In hippocampal HT 22 cell homogenates, levels of LPO were reduced to 74.8 +/- 5.5% by estrone and to 47.8 +/- 6.2% by 17beta-estradiol. In living neocortical cultures, 17beta-estradiol decreased iron-induced LPO to 79.2 +/- 4.8% and increased the survival of cultured neuronal cells. Of the other steroid compounds tested (corticosterone, progesterone, testosterone), only progesterone decreased LPO in HT 22 cell homogenates. In HBHs, LPO was dose-dependently increased by iron concentrations from 2.7 to 6.0 mM. Incubation with estrogens resulted in a dose-dependent inhibition of LPO to 53.8 +/- 8.6% with 10 microM 17beta-estradiol, whereas estrone failed to affect iron-induced LPO to a significant extent. Nonestrogenic steroids, including hydrocortisol, did not show significant effects on LPO in HBHs.


Subject(s)
Brain/metabolism , Corticosterone/pharmacology , Estradiol/pharmacology , Lipid Peroxidation/drug effects , Neocortex/metabolism , Neurons/metabolism , Animals , Brain/drug effects , Cell Survival/drug effects , Cells, Cultured , Chlorides , Ferric Compounds/pharmacology , Humans , Kinetics , Male , Malondialdehyde/analysis , Neurons/cytology , Neurons/drug effects , Progesterone/pharmacology , Rats , Rats, Wistar , Testosterone/pharmacology , Thiobarbituric Acid Reactive Substances/analysis , Vitamin E/pharmacology
5.
FASEB J ; 13(9): 1065-72, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10336889

ABSTRACT

Amphetamineanalogs have emerged as popular recreational drugs of abuse. The number of reports of these substances producing severe acute toxicity and death is increasing. In 'Ecstasy' -associated deaths, focal necrosis in the liver and individual myocytic necrosis has been reported. Furthermore, serotonergic and dopaminergic neuronal cell damage has been observed in experimental amphetamine intoxication in laboratory animals. Here we demonstrate that subchronic exposure to D-amphetamine, methamphetamine, methylenedioxyamphetamine, and methylenedioxymethamphetamine ('Ecstasy') results in significant neurotoxicity in rat neocortical neurons in vitro. This neuronal cell death is accompanied by endonucleosomal DNA cleavage and differential expression of anti- and proapoptotic bcl-xL/S splice variants. In addition, we observed pronounced induction of cell stress-associated transcription factor c-jun and translation initiation inhibitor p97 after amphetamine treatment. These data support that the neurotoxic effects of different amphetamines are extended to rat neocortical neurons and that apoptotic pathways are involved in amphetamine-induced neurotoxicity.


Subject(s)
Amphetamines/toxicity , Apoptosis , Neocortex/drug effects , Neurons/drug effects , Proto-Oncogene Proteins c-bcl-2/genetics , 3,4-Methylenedioxyamphetamine/toxicity , Alternative Splicing , Animals , DNA Fragmentation , Dextroamphetamine/toxicity , Gene Expression Regulation , Methamphetamine/toxicity , N-Methyl-3,4-methylenedioxyamphetamine/toxicity , Neocortex/cytology , Neurons/cytology , Rats , Rats, Wistar , bcl-X Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...